Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. [electronic resource]
- Cancer research Nov 2004
- 8101-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
10.1158/0008-5472.CAN-04-2361 doi
Adaptor Proteins, Signal Transducing--analysis Adolescent Adult Blotting, Western Caspases--physiology Cell Line, Tumor Drug Resistance, Neoplasm Fas-Associated Death Domain Protein Humans Immunohistochemistry Leukemia, Myeloid, Acute--drug therapy Microscopy, Confocal Microscopy, Fluorescence Middle Aged Prognosis fas Receptor--analysis